Cargando…
Serum contents of endocannabinoids are correlated with blood pressure in depressed women
BACKGROUND: Depression is known to be a risk factor for cardiovascular diseases but the underlying mechanisms remain unclear. Since recent preclinical evidence suggests that endogenous agonists of cannabinoid receptors (endocannabinoids) are involved in both cardiovascular function and depression, w...
Autores principales: | Ho, WS Vanessa, Hill, Matthew N, Miller, Gregory E, Gorzalka, Boris B, Hillard, Cecilia J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334711/ https://www.ncbi.nlm.nih.gov/pubmed/22373123 http://dx.doi.org/10.1186/1476-511X-11-32 |
Ejemplares similares
-
Suppression of Amygdalar Endocannabinoid Signaling by Stress Contributes to Activation of the Hypothalamic-Pituitary-Adrenal Axis
por: Hill, Matthew N., et al.
Publicado: (2009) -
Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder
por: MEYER, JACOB D., et al.
Publicado: (2019) -
Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors
por: Fitzgerald, Jacklynn M., et al.
Publicado: (2021) -
Serum Concentrations of the Endocannabinoid, 2-Arachidonoylglycerol, in the Peri-Trauma Period Are Positively Associated with Chronic Pain Months Later
por: Trevino, Colleen M., et al.
Publicado: (2022) -
Role of endocannabinoid signaling in a septohabenular pathway in the regulation of anxiety- and depressive-like behavior
por: Vickstrom, Casey R., et al.
Publicado: (2020)